{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:22:30Z","timestamp":1790709750001,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.lfs.2016.04.029","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T21:07:40Z","timestamp":1462050460000},"page":"15-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Evaluation of role of telmisartan in combination with 5-fluorouracil in gastric cancer cachexia"],"prefix":"10.1016","volume":"154","author":[{"given":"Shreesha","family":"Sukumaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetal J.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-5452","authenticated-orcid":false,"given":"Bhoomika M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2016.04.029_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2016.04.029_bb0010","series-title":"Pocket Book for Cancer Supportive Care","article-title":"Cancer cachexia","author":"Del Fabbro","year":"2012"},{"key":"10.1016\/j.lfs.2016.04.029_bb0015","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1155\/2011\/601434","article-title":"Cancer cachexia: mechanisms and clinical implications.","volume":"2011","author":"Donohoe","year":"2011","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.lfs.2016.04.029_bb0020","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.biopha.2013.08.005","article-title":"Malnutrition, anorexia and cachexia in cancer patients: a mini-review on pathogenesis and treatment","volume":"67","author":"Nicolini","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2016.04.029_bb0025","first-page":"347","article-title":"Cardiac alterations in cancer-induced cachexia in mice","volume":"37","author":"Tian","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2016.04.029_bb0030","first-page":"59","article-title":"Chemotherapy-induced cardiotoxicity","volume":"8","author":"Florescu","year":"2013","journal-title":"Maedica (Buchar)"},{"key":"10.1016\/j.lfs.2016.04.029_bb0035","first-page":"253","article-title":"Cardiotoxicity due to cancer therapy","volume":"38","author":"Khakoo","year":"2011","journal-title":"Tex. Heart Inst. J."},{"key":"10.1016\/j.lfs.2016.04.029_bb0040","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ctrv.2013.03.005","article-title":"Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systemic review of incidence, manifestations and predisposing factors","volume":"39","author":"Polk","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.lfs.2016.04.029_bb0045","series-title":"Essentials of Palliative Care. Multidisciplinary Approval and Co-ordination of Care","first-page":"59","author":"Vadivelu","year":"2013"},{"key":"10.1016\/j.lfs.2016.04.029_bb0050","first-page":"2471","article-title":"Expression of peroxisome proliferator activated receptor (PPAR) gamma in human lung cancer","volume":"21","author":"Inoue","year":"2001","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lfs.2016.04.029_bb0055","first-page":"1","article-title":"Coprinus comatus cap inhibits adipocyte differentiation via regulation of PPAR\u03b3 and Akt signaling pathway","volume":"9","author":"Park","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lfs.2016.04.029_bb0060","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1074\/jbc.M210062200","article-title":"Adipocyte specific gene expression and adipogenicsteatosis in the mouse liver due to peroxisome proliferator activated receptor gamma 1 (PPAR\u03b31) overexpression","volume":"278","author":"Yu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2016.04.029_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.09.034","article-title":"Aldosterone and angiotensin: role in diabetes and cardiovascular diseases","volume":"697","author":"Patel","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.04.029_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0029-1212088","article-title":"Crosstalk between insulin and angiotensin II signalling systems","volume":"107","author":"Folli","year":"1999","journal-title":"Exp. Clin. Endocrinol. Diabetes."},{"key":"10.1016\/j.lfs.2016.04.029_bb0075","first-page":"41","article-title":"Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers","volume":"25","author":"Kakuta","year":"2005","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.lfs.2016.04.029_bb0080","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR\u03b3-modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2016.04.029_bb0085","article-title":"Telmisartan manifests powerful anti-inflammatory effects beyond class effects of angiotensin II type 1 blocker by inhibiting tumor necrosis factor alpha-induced interleukin 6 expressions through peroxisome proliferator activated receptory activation","volume":"118","author":"Ichiki","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2016.04.029_bb0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11010-008-9772-y","article-title":"Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats","volume":"314","author":"Goyal","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2016.04.029_bb0095","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1734-1140(11)70611-9","article-title":"Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats","volume":"63","author":"Goyal","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2016.04.029_bb0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/AC.67.2.2154211","article-title":"Beneficial role of spironolactone, telmisartan and their combination on isoproterenol induced cardiac hypertrophy","volume":"67","author":"Goyal","year":"2012","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.lfs.2016.04.029_bb0105","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00520-010-0972-0","article-title":"Animal models of the cancer anorexia\u2013cachexia syndrome","volume":"19","author":"Bennani-Baiti","year":"2011","journal-title":"Support. Care Cancer"},{"issue":"5","key":"10.1016\/j.lfs.2016.04.029_bb0110","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.3390\/ijms12053340","article-title":"Lycopene enhances antioxidant enzyme activities and immunity function in N-methyl-N\u2032-nitro-N-nitrosoguanidine-induced gastric cancer rats","volume":"12","author":"Luo","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2016.04.029_bb0115","first-page":"121","article-title":"Protective role of gossypol against N-methyl-N\u2032-nitro-N-nitrosoguanidine (MNNG) induced gastric carcinogenesis in experimental rats","volume":"2","author":"Gunassekaran","year":"2010","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.lfs.2016.04.029_bb0120","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/FJC.0b013e3181be75cc","article-title":"Investigation into the cardiac effects of spironolactone in the experimental model of type 1 diabetes","volume":"54","author":"Goyal","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2016.04.029_bb0125","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0033-1345168","article-title":"Effect of spironolactone on cardiovascular complications associated with type-2 diabetes in rats","volume":"121","author":"Patel","year":"2013","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.lfs.2016.04.029_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000497705","article-title":"Comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril on diabetes induced cardiovascular complications in type 1 diabetes in rats","volume":"19","author":"Goyal","year":"2011","journal-title":"Int. J. Diabetes Metab."},{"key":"10.1016\/j.lfs.2016.04.029_bb0135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/10641963.2013.827699","article-title":"Type 2 diabetes induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril","volume":"36","author":"Patel","year":"2014","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.lfs.2016.04.029_bb0140","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1177\/0960327112446817","article-title":"Perindopril protects against streptozotocin induced hyperglycemic myocardial damage\/alterations","volume":"31","author":"Patel","year":"2012","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.lfs.2016.04.029_bb0145","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pharep.2014.02.004","article-title":"Beneficial role of tamoxifen in experimentally induced cardiac hypertrophy","volume":"66","author":"Patel","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2016.04.029_bb0150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2014.01.063","article-title":"Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus","volume":"728","author":"Patel","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.04.029_bb0155","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1139\/cjpp-2013-0348","article-title":"Beneficial role of tamoxifen in isoproterenol induced myocardial infarction","volume":"92","author":"Rayabarapu","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2016.04.029_bb0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituricacid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2016.04.029_bb0165","first-page":"882","article-title":"Improved method for the determination of blood glutathione","volume":"61","author":"Beutler","year":"1963","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.lfs.2016.04.029_bb0170","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","article-title":"The role of superoxide anion in the auto-oxidation of epinephrine and simple assay for superoxide dismutase","volume":"247","author":"Misra","year":"1972","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2016.04.029_bb0175","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.2174\/138161211798220918","article-title":"Cytokine signaling modulates blood-brain barrier function","volume":"17","author":"Pan","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2016.04.029_bb0180","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbrc.2008.07.068","article-title":"Regulation of Ppar\u03b3 function by TNF-\u03b1","volume":"374","author":"Ye","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2016.04.029_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/01.HYP.0000235865.03528.f1","article-title":"Tumor necrosis factor- \u03b1 and vascular angiotensin II in estrogen deficient rats","volume":"48","author":"Arenas","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2016.04.029_bb0190","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s00592-005-0176-0","article-title":"Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator","volume":"42","author":"Kurtz","year":"2005","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.lfs.2016.04.029_bb0195","doi-asserted-by":"crossref","first-page":"H923","DOI":"10.1152\/ajpheart.01278.2005","article-title":"An emerging role for inflammatory cytokines in hypertension","volume":"290","author":"Granger","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2016.04.029_bb0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0277-5379(91)90050-N","article-title":"Elevated energy expenditure in cancer patients with solid tumours","volume":"27","author":"Hyltander","year":"1991","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lfs.2016.04.029_bb0205","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.HYP.27.6.1284","article-title":"Changes in the baro reflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats","volume":"27","author":"Oliveira","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2016.04.029_bb0210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1079\/PNS19920036","article-title":"The mechanisms and treatment of weight loss in cancer","volume":"51","author":"Fearon","year":"1992","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.lfs.2016.04.029_bb0215","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ajcn\/84.3.475","article-title":"The underappreciated role of muscle in health and disease","volume":"84","author":"Wolfe","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.lfs.2016.04.029_bb0220","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bjc.6602725","article-title":"Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia","volume":"93","author":"Sanders","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2016.04.029_bb0225","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2016.04.029_bb0230","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.febslet.2004.09.027","article-title":"An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT 4 protein expression in 3T3L1 adipocytes","volume":"576","author":"Fujimoto","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2016.04.029_bb0235","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","article-title":"Cancer cachexia: developing multimodal therapy for a multidimensional problem","volume":"44","author":"Fearon","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lfs.2016.04.029_bb0240","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13539-011-0051-5","article-title":"The role of insulin resistance in the development of muscle wasting during cancer cachexia","volume":"3","author":"Honors","year":"2012","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.lfs.2016.04.029_bb0245","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/PL00012351","article-title":"Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia","volume":"23","author":"Fearon","year":"1999","journal-title":"World J. Surg."},{"key":"10.1016\/j.lfs.2016.04.029_bb0250","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/01635589809514722","article-title":"Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients","volume":"32","author":"O'Gorman","year":"1998","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.lfs.2016.04.029_bb0255","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/bjc.1996.294","article-title":"The relationship between weight loss and interleukin 6 in non-small-cell lung cancer","volume":"73","author":"Scott","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2016.04.029_bb0260","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassmann","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2016.04.029_bb0265","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00432-003-0526-7","article-title":"Recombinant human erythropoietin attenuates weight loss in a murine cancer cachexia model","volume":"130","author":"van Halteren","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.lfs.2016.04.029_bb0270","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0030-4220(87)90090-9","article-title":"Gamma-glutamyltranspeptidase activity in human oral squamous cell carcinoma","volume":"64","author":"Mock","year":"1987","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"10.1016\/j.lfs.2016.04.029_bb0275","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"oxidative stress, inflammation, and cancer: how are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"free radic. biol. med."},{"key":"10.1016\/j.lfs.2016.04.029_bb0280","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0165-6147(03)00233-5","article-title":"The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases","volume":"24","author":"Cai","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2016.04.029_bb0285","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2741\/2802","article-title":"Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists","volume":"13","author":"Kapadia","year":"2008","journal-title":"Front. Biosci."},{"issue":"3","key":"10.1016\/j.lfs.2016.04.029_bb0290","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/0973-029X.86670","article-title":"Cancer cachexia","volume":"15","author":"Dhanapal","year":"2011","journal-title":"J. Oral Maxillofac. Pathol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516302491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516302491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T23:25:13Z","timestamp":1748906713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516302491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":58,"alternative-id":["S0024320516302491"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.04.029","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of role of telmisartan in combination with 5-fluorouracil in gastric cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}